Astrazeneca PLC (AZN)

AstraZeneca and the University of Virginia in Charlottesville Tuesday announced that they have entered into a strategic research collaboration to enhance development of new treatments primarily for coronary artery disease (CAD) with a secondary focus on peripheral vascular disease (PAD).
http://www.prnewswire.com/news-releases/astrazeneca-and-the-university-of-virginia-sign-strategic-research-collaboration-to-develop-novel-treatments-for-cardiovascular-disease-79304982.html

Dec 15 · 10:42:00 AM
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter